EeCentrocin EC1-17KV

General Information


DRACP ID  DRACP04275

Peptide Name   EeCentrocin EC1-17KV

Sequence  GWWRRTVKKVRNAVRKV

Sequence Length  17

UniProt ID  A0A144LUY5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C97H163N35O20

Absent amino acids  CDEFHILMPQSY

Common amino acids  RV

Mass  242514

Pl  12.99

Basic residues  7

Acidic residues  0

Hydrophobic residues  7

Net charge  7

Boman Index  -6197

Hydrophobicity  -102.94

Aliphatic Index  74.12

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  687.5

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32403086

Title  Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18789

DRACP is developed by Dr.Zheng's team.